Bisphenol S induces adipogenesis in primary human preadipocytes from female donors

Endocrinology

Volumn 157, Issue 4, 2016, Pages 1397-1407

  Boucher, Jonathan G ^a   Ahmed, Shaimaa ^a   Atlas, Ella ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADIPOCYTE PROTEIN 2; BISPHENOL S; FULVESTRANT; LIPID; LIPOPROTEIN LIPASE; MESSENGER RNA; MIFEPRISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOL DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG; BIS(4-HYDROXYPHENYL)SULFONE; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONIST; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; SULFONE;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL METABOLISM; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FOLDING; REPORTER GENE; UPREGULATION; ADIPOCYTE; ADULT; ANALOGS AND DERIVATIVES; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; LIPID METABOLISM; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ADULT; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONISTS; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; LIPID METABOLISM; LIPOPROTEIN LIPASE; MICROSCOPY, FLUORESCENCE; PHENOLS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SULFONES;

EID: 84964452051     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1872     Document Type: Article

References (50)

1. Fleisch AF, Sheffield PE, Chinn C, Edelstein BL, Landrigan PJ. Bisphenol A and related compounds in dental materials. Pediatrics. 2010;126:760-768.
2. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011; 127:27-34.
3. Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol. 2012;354:74-84.
4. Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in U.S. children. Am J Epidemiol. 2013;177:1263-1270.
5. Somm E, Schwitzgebel VM, Toulotte A, et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect. 2009;117:1549-1555.
6. Boucher JG, Boudreau A, Ahmed S, Atlas E. In vitro effects of bisphenol A-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ Health Perspect. 2015;123: 12871293.
7. Masuno H, Kidani T, Sekiya K, et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res. 2002;43:676-684.
8. Atlas E, Pope L, Wade MG, Kawata A, Boudreau A, Boucher JG. Bisphenol A increases aP2 expression in 3T3L1 by enhancing the transcriptional activity of nuclear receptors at the promoter. Adipocyte. 2014;3:170-179.
9. Boucher JG, Boudreau A, Atlas E. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr Diabetes. 2014;4:e102.
10. Liao C, Kannan K. A survey of bisphenol A and other bisphenol analogues in foodstuffs from nine cities in China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31:319-329.
11. Liao C, Liu F,MoonHB, Yamashita N, Yun S, Kannan K. Bisphenol analogues in sediments from industrialized areas in the United States, Japan, and Korea: spatial and temporal distributions. Environ Sci Technol. 2012;46:11558-11565.
12. Gallart-Ayala H, Moyano E, Galceran MT. Analysis of bisphenols in soft drinks by on-line solid phase extraction fast liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2011;683: 227-233.
13. Viñas P, Campillo N, Martínez-Castillo N, Hernández-Córdoba M. Comparison of two derivatization-based methods for solid-phase microextraction-gas chromatography-mass spectrometric determination of bisphenol A, bisphenol S and biphenol migrated from food cans. Anal Bioanal Chem. 2010;397:115-125.
14. Becerra V, Odermatt J. Detection and quantification of traces of bisphenol A and bisphenol S in paper samples using analytical pyrolysis-GC/MS. Analyst. 2012;137:2250-2259.
15. Liao C, Liu F, Alomirah H, et al. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012;46:6860-6866.
16. Zhou X, Kramer JP, Calafat AM, Ye X. Automated on-line columnswitching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;944:152-156.
17. Rosenmai AK, Dybdahl M, Pedersen M, et al. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci. 2014; 139:35-47.
18. Danzl E, Sei K, Soda S, IkeM,FujitaM.Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater. Int J Environ Res Public Health. 2009;6:1472-1484.
19. Naderi M, Wong MY, Gholami F. Developmental exposure of zebrafish (Danio rerio) to bisphenol-S impairs subsequent reproduction potential and hormonal balance in adults. Aquat Toxicol. 2014; 148:195-203.
20. Ji K, Hong S, Kho Y, Choi K. Effects of bisphenol s exposure on endocrine functions and reproduction of zebrafish. Environ Sci Technol. 2013;47:8793-8800.
21. Chen MY, Ike M, Fujita M. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ Toxicol. 2002;17:80-86.
22. Kang JS, Choi JS, Kim WK, Lee YJ, Park JW. Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on aMVLNcell using a luciferase reporter gene assay. Reprod Biol Endocrinol. 2014;12:102.
23. Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPAR α and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293-302.
24. Chapman AB, Knight DM, Ringold GM. Glucocorticoid regulation of adipocyte differentiation: hormonal triggering of the developmental program and induction of a differentiation-dependent gene. J Cell Biol. 1985;101:1227-1235.
25. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring). 2010;18:1283-1288.
26. Héliès-Toussaint C, Peyre L, Costanzo C, Chagnon MC, Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol Appl Pharmacol. 2014; 280:224-235.
27. Greenspan P, Mayer EP, Fowler SD. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 1985;100:965-973.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(C(T)) method. Methods. 2001;25:402-408.
29. Rival Y, Stennevin A, Puech L, et al. Human adipocyte fatty acidbinding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor γ ligands. J Pharmacol Exp Ther. 2004;311:467-475.
30. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activatesPPAR α through the production of endogenous ligand. Proc Natl Acad Sci USA. 1998;95:4333-4337.
31. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829-839.
32. Goldinger DM, Demierre AL, Zoller O, et al. Endocrine activity of alternatives to BPA found in thermal paper in Switzerland. Regul Toxicol Pharmacol. 2015;71:453-462.
33. Eladak S, Grisin T, Moison D, et al. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril. 2015;103:11-21.
34. Ayala-Sumuano JT, Velez-Delvalle C, Beltran-Langarica A, Marsch-Moreno M, Cerbon-Solorzano J, Kuri-Harcuch W. Srebf1a is a key regulator of transcriptional control for adipogenesis. Sci Rep. 2011;1:178.
35. Boucher JG, Husain M, Rowan-Carroll A, Williams A, Yauk CL, Atlas E. Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014;22:2333-2343.
36. Tomlinson JJ, Boudreau A, Wu D, et al. Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors. Mol Endocrinol. 2010;24:104-113.
37. Kuruto-Niwa R, Nozawa R, Miyakoshi T, Shiozawa T, Terao Y. Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ Toxicol Pharmacol. 2005;19:121-130.
38. Brasaemle DL. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007;48:2547-2559.
39. DeBosscher K, Beck IM, Dejager L, et al. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1. Cell Mol Life Sci. 2014;71:143-163.
40. Rogatsky I, Wang JC, Derynck MK, et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA. 2003;100:13845-13850.
41. Lee HY, Gao X, Barrasa MI, et al. PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature. 2015;522:474-477.
42. Jones JR, Barrick C, Kim KA, et al. Deletion of PPAR α in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA. 2005;102:6207-6212.
43. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, Wahli W. Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol Cell. 1993;77:67-76.
44. Hamza MS, Pott S, Vega VB, et al. De-novo identification ofPPAR α/ RXR binding sites and direct targets during adipogenesis. PLoS One. 2009;4:e4907.
45. Ahmadian M, Suh JM, Hah N, et al. PPAR α signaling and metabolism: the good, the bad and the future. NatMed. 2013;19:557-566.
46. Roelofs MJ, van den Berg M, Bovee TF, Piersma AH, van Duursen MB. Structural bisphenol analogues differentially target steroidogenesis in murine MA-10 Leydig cells as well as the glucocorticoid receptor. Toxicology. 2015;329:10-20.
47. Kitamura S, Suzuki T, Sanoh S, et al. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci. 2005;84:249-259.
48. Blouin K, Nadeau M, Mailloux J, et al. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. Am J Physiol Endocrinol Metab. 2009;296:E244-E255.
49. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6:1-7.
50. Gramec Skledar D, Troberg J, Lavdas J, Peterlin Maši L, Finel M. Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10. Xenobiotica. 2015;45:511-519.